Shoaie, Saeed

Multi-omics characterization of improved cognitive functions in Parkinson's disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based Approach

Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease

Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases (Retraction of Vol 314, art no 121325, 2023)

Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients

Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach

A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis

Systems Biology Approaches to Decipher the Underlying Molecular Mechanisms of Glioblastoma Multiforme

Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis

Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19